(Q33364005)

English

Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

scientific article

Statements

Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG). (English)
Dimitrios Tsavdaridis
Anna Kalogera-Fountzila
Gerassimos Aravantinos
Evangelia Razis
Haralambos P Kalofonos
Pavlos Papakostas
Maria Karina
Helen Gogas

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit